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ABSTRACT
We have analyzed the ability of A165V, V169I/D170N, and P536L mutations to suppress pma1 dominant
lethal alleles and found that the P536L mutation is able to suppress the dominant lethality of the pma1-
R271T, -D378N, -D378E, and -K474R mutant alleles. Genetic and biochemical analyses of site-directed
mutants at Pro-536 suggest that this amino acid may not be essential for function but is important for
biogenesis of the ATPase. Proteins encoded by dominant lethal pma1 alleles are retained in the endoplasmic
reticulum, thus interfering with transport of wild-type Pma1. Immuno¯uorescence studies of yeast condi-
tionally expressing revertant alleles show that the mutant enzymes are correctly located at the plasma
membrane and do not disturb targeting of the wild-type enzyme. We propose that changes in Pro-536
may in¯uence the folding of the protein encoded by a dominant negative allele so that it is no longer
recognized and retained as a misfolded protein by the endoplasmic reticulum.
THE yeast plasma membrane H1-ATPase from Sac- ci®c suppressors, as they were able to suppress mutationslocated either at the carboxyl terminus (Eraso and Por-charomyces cerevisiae is an electrogenic proton pump
essential for nutrient uptake and intracellular pH regu- tillo 1994) or at the ATP-binding domain of the en-
zyme (Maldonado and Portillo 1995). Similar allele-lation (see review by Serrano 1991). The ATPase be-
longs to the P-type, ion-translocating ATPase family, nonspeci®c suppressors have been isolated in other sys-
tems and appear to affect protein stability (Shortlewhich forms an acyl-phosphate intermediate during ca-
talysis and is sensitive to vanadate (Pedersen and Cara- and Lin 1985; Thomas et al. 1991). In this report, we
show that the P536L mutation is able to suppress domi-foli 1987).
The genes encoding members of the P-type ATPase nant lethal pma1 mutations located in three different
regions of the ATPase. Further analysis of site-directedfamily from bacterial, fungal, plant, and animal cells
have been cloned and sequenced, in each case allowing mutants at Pro-536 suggests that this residue is impor-
tant for biogenesis of the enzyme and that suppressionthe primary structure of the protein to be deduced.
Comparison of the P-ATPases' amino acid sequences of dominant lethality is probably caused by compensa-
tory structural alterations that alleviate retention of theshowed that they share several regions of homology
and a common topology (Serrano 1989; Goffeau and mutant protein at the ER.
Green 1990; Wach et al. 1992). Site-directed mutagene-
sis and intragenic suppressor analysis have been used
MATERIALS AND METHODSto probe structure-function relationships of the yeast
enzyme. Site-directed mutagenesis has allowed the iden- Yeast strains and growth conditions: Yeast strain XZ611 is
ti®cation of a series of mutations that cause cell growth GAL1 MATa ura3 leu2 trp1 (Harris et al. 1994), and it was
arrest even when wild-type Pma1 protein is coexpressed used to determine the dominant lethality of pma1 genes and in
immuno¯uorescence experiments. Strain SY4 is GAL1 MATa(Harris et al. 1994; Portillo 1997). Expression of
ura3 leu2 his4 sec6 pma1::YIpGAL-PMA1 and was used for ex-these dominant lethal proteins leads to the accumula-
pression of the ATPase in secretory vesicles (Nakamoto et al.tion of mutant and wild-type proteins in subplasma 1991). Synthetic media with 2% dextrose (SD), 2% lactic acid
membrane structures probably derived from the endo- (SL), or 2% galactose (SG) and the appropriate requirements
plasmic reticulum (ER; Harris et al. 1994). From intra- were used (Rose et al. 1990). Yeast cells were transformed
using the lithium acetate procedure (Ito et al. 1983). To testgenic suppression analysis of selected pma1 alleles, three
the dominant lethality of the pma1 alleles, transformants weremutations (A165V, V169I/D170N, and P536L) were
transferred to SL medium and, after growth, suspended inidenti®ed that exhibited characteristics of allele-nonspe- water at a cell density of 2 3 107 cell/ml, and 5 ml was dropped
on SG.
Construction of pma1 alleles: The pma1 genes containing
Pro-536 mutations were produced by site-directed mutagene-Corresponding author: Francisco Portillo, Instituto de Investigaciones
sis. The Amersham Kit for oligonucleotide-directed mutagene-BiomeÂdicas, C/Arturo Duperier, 4, E-28029 Madrid, Spain.
E-mail: fportillo@biomed.iib.uam.es sis (Amersham Corp., Arlington Heights, IL) was used to intro-
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duce the mutations into a 2.2-kb XbaI fragment of the PMA1 BamHI-HindIII fragments containing the Pro-536 substitutions
gene previously subcloned into M13mp19. After mutagenesis, were ligated into plasmid pPMA1.2 (Nakamoto et al. 1991)
the entire XbaI fragment was sequenced to verify that only that had been digested with BamHI and HindIII. After the
the nucleotide changes introduced by the mutagenic oligonu- fragments were moved into plasmid pPMA1.2, a 3.77-kb SacI-
cleotides were obtained. The XbaI fragments containing the HindIII fragment containing the entire ATPase coding se-
mutation were moved into the full-length PMA1 gene in plas- quence was cloned into vector YCp2HSE (Nakamoto et al.
mid pRS427 (Vallejo and Serrano 1989). Plasmid pRS427 1991), placing the mutant alleles under the control of a heat-
is a derivative of the URA3 single-copy plasmid YCp50 (Rose shock-inducible promoter. The resulting plasmids were trans-
and Broach 1991) and containts the PMA1 gene joined to formed into strain SY4 (Nakamoto et al. 1991). This strain
the GAL1 promoter. The pma1 alleles in Tables 1 and 3 were has the chromosomal PMA1 gene under the control of the
constructed by placing the pma1 genes containing dominant GAL1 promoter and also carries the sec6-4 mutation that
lethal mutations under the control of the galactose-inducible blocks fusion of secretory vesicles with the plasma membrane.
promoter in plasmid pRS427, as described in Portillo For expression studies, transformed SY4 were grown to mid-
(1997). The Pro-536 mutations were subsequently combined exponential phase (OD660z0.5) on SG and shifted to SD for
in cis with the different dominant lethal mutations by ex- 3 hr to turn off transcription of chromosomal PMA1 and then
change of a 2.2-kb XbaI fragment containing the allele-non- shifted to 378 for 2 hr to turn on expression of the plasmid-
speci®c mutations with the corresponding fragment in the borne gene and block fusion of secretory vesicles with plasma
dominant lethal GAL1::pma1 gene construction. All mutant membrane. Secretory vesicles were then isolated by differen-
constructions were veri®ed by sequencing. The hemagglutinin tial centrifugation as described (Nakamoto et al. 1991).
(HA)-tagged pma1 alleles used in this study were generated Biochemical methods: Plasma membranes were puri®ed
by exchange of a 3.4-kb BstEII-HindIII fragment containing from glucose-metabolizing yeast by differential and sucrose
the desired mutations with the corresponding fragment in gradient centrifugation (Serrano 1983). Immunoquanti®ca-
plasmid pFP302. The plasmid pFP302 is identical to pRS427, tion of the ATPase was performed as described (Rao and
except that it carries an HA-tagged wild-type PMA1 under Slayman 1993). ATPase activity was assayed at pH 6.5 with
the control of the GAL1 promoter. The nine±amino acid HA 5mm ATP (Serrano 1988). H1 pumping into secretory vesi-
epitope was introduced after the second amino acid of the cles was monitored by ¯uorescence quenching of acridine
ATPase by site-directed mutagenesis (Portillo 1997). All mu- orange (Nakamoto et al. 1991). Proton ef¯ux from the cells
tant constructions were veri®ed by sequencing. was measured after starvation at 48 and glucose addition at
When coexpression of dominant lethal and wild-type pro- 308 (Serrano 1980). Protein concentration was determinedteins was required, cells were transformed with a pRS427 deriv- by the Bradford method (Bradford 1976) with the Bio-Radative containing different dominant lethal mutations and plas- Protein Assay Reagent (Bio-Rad Laboratories, Hercules, CA)
mid pFP239. The plasmid pFP239 is a derivative of the LEU2 and bovine IgG as standard. The monoclonal antibodiessingle-copy plasmid pSB32 (Rose and Broach 1991) and con- Mab12 against the yeast ATPase (Serrano et al. 1993) andtains an HA-tagged wild-type PMA1 under the control of the 12CA5 against the HA epitope (Wilson et al. 1984) were usedGAL1 promoter.
in immunoquanti®cation and immunoblot. Plasma mem-Replacement of the P536N and P536L mutant alleles by the
brane proteins were separated by SDS-PAGE on 8% acrylamidechromosomal wild-type PMA1: The ATPase gene fragments
using the Laemmli system (Laemmli 1970). Western blot withcontaining the Pro-536 substitutions were subcloned by ex-
second antibody conjugated to alkaline phosphatase (Bio-change of a 2.2-kb XbaI fragment in plasmid pFP36. Plasmid
Rad) was as described (Blake et al. 1984).pFP36 is a derivative of pUC18 and contains a PMA1 gene in
which a URA3 marker was introduced into a synthetic XhoI
linker located at the intergenic region between PMA1 and
LEU1 (Serrano et al. 1986). Strain FPY183 was transformed RESULTS
with the HindIII pma1::URA3 fragments containing the Pro-
536 mutations. Strain FPY183, derived from autodiploid W303 Suppression spectrum of allele-nonspeci®c suppres-
(Portillo 1997), is heterozygous for a LEU2-marked deletion sors: The A165V, V169I/D170N, and P536L mutations
of PMA1 in which the 3.37-kb EcoRV-SalI PMA1±coding region were selected previously by suppression of the otherwise
was replaced with a 2.3-kb LEU2 fragment. After transforma-
unrelated S911A/T912A (Eraso and Portillo 1994)tion, Ura1 Leu2 diploids were selected and tetrads were dis-
and K474R (Maldonado and Portillo 1995) muta-sected. The diploid pma1-P536N::URA3/PMA1 yielded only
two Ura2 viable spores, and the pma1-P536L::URA3/PMA1 tions. The fact that the K474R mutation is a dominant
rendered four viable spores. In each case, two independent lethal allele (Portillo 1997) prompted us to examine
diploids were dissected and segregation of 15 tetrads of each the effect of the A165V, V169I/D170N, and P536L muta-were studied. After growth and analysis of the Ura1 segregants
tions on the dominant lethality of several other pma1containing the P536L mutation, genomic DNA-containing
mutations located in different regions of the enzyme.portions of the pma1-P536L gene were ampli®ed by polymer-
ase chain reaction and sequenced to ensure that only the For this, we created novel combinations of dominant
P536L mutation was present. lethal and suppressor mutations in cis, and each of the
Fluorescence microscopy: Strain XZ611, transformed with new pma1 alleles was placed under the control of thedifferent pma1 alleles, was selected in SD medium. To induce
GAL1 promoter (see materials and methods). Plas-the GAL1::pma1 gene expression, cells were cultured in SL
mids carrying the GAL1::pma1 alleles were used to trans-medium overnight at 308, collected, resuspended in SG me-
dium, and cultured for 5 hr at 308. Cells were ®xed and stained form a wild-type strain. Under these conditions, yeast
for immuno¯uorescence as described (Pringle et al. 1991). cells carrying a dominant lethal allele arrest growth
Localization of HA-tagged Pma1 was determined by immuno-
when they are transferred from glucose- to galactose-¯uorescence using a rhodamine-conjugated anti-HA antibody
containing medium. The results of this analysis for dom-(Boehringer Mannheim, Mannheim, Germany).
Expression of the ATPase in secretory vesicles: The 2.6-kb inant lethality of the different in vitro-generated alleles
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TABLE 1
Suppression of dominant lethal mutations by
allele-nonspeci®c suppressors
Allele-nonspeci®c suppressors
Dominant lethal
mutations A165V V169I/D170N P536L
D200N nd nd 2
E233Q nd nd 2
R271T 2 2 1
P335A 2 2 2
D378N 2 2 1
D378E 2 2 1
D378T 2 2 2
K474R 1 1 1
Mutations were combined in cis, and the resulting alleles
were placed under the control of the galactose-inducible pro-
moter. Suppression is de®ned as the ability of the XZ611 yeast
strain to grow on SG medium.
1, suppression; 2, no suppression; nd, combination of mu-
tations was not done.
Figure 1.ÐSpot test for growth of yeast strains expressingare presented in Table 1. Only P536L reversion could dominant lethal alleles of PMA1. Strains are recombinant,
suppress, in addition to K474R, several other dominant carrying the PMA1 wild-type allele or the indicated pma1 allele
lethal mutations tested. under the control of the galactose-inducible promoter. The
test was performed as indicated in materials and methods.Genetic and biochemical analyses of Pro-536 substitu-
Plates were photographed after 36 hr at 308.tion: To examine the effect of amino acid replacement
on suppression ability, we created by site-directed muta-
genesis new pma1 alleles in which Pro-536 was replaced protein, and both the HA-tagged and dominant lethal
with residues of different size and charge (Pro-536 → allele were coexpressed under the control of the GAL1
A, V, I, N, G, T, H, K, D). Before the above-mentioned promoter in the same cell. The location of the wild-type
analysis, the phenotype of the pma1 alleles generated HA-tagged protein was studied in galactose-cultured
was determined. We ®rst examined whether or not the cells by immuno¯uorescent staining of wild-type Pma1
new mutations were dominant lethal. For this, the mu- with the anti-HA monoclonal antibody (Figure 2). When
tant ATPase genes were placed under control of the HA-tagged wild-type protein was induced simultane-
GAL1 promoter and transformed into the appropriate ously with the dominant lethal protein, the anti-HA
wild-type yeast to test for growth in galactose-containing antibody decorated a set of cytoplasmic structures simi-
medium. The results of this test for dominant lethality lar to those observed for other dominant negative Pma1
of the different site-directed mutations are summarized proteins (Harris et al. 1994; Portillo 1997). When
in Figure 1. Substitution of Pro-536 by either small un- only the HA-tagged dominant negative proteins were
charged (Gly) or charge residues (His, Lys, and Asp) expressed under the control of the GAL1 promoter, the
renders a dominant lethal allele. same staining of cytoplasmic dots was observed (data not
The expression of dominant lethal proteins blocks shown). These results suggest that dominant lethality of
their transport to the plasma membrane, and the pro- pma1-P536G, -P536H, -P536K, and -P536D is caused by
teins are accumulated into cytoplasmic structures called the interference of the mutant protein with the trans-
ªBip bodiesº (Supply et al. 1993; Harris et al. 1994). The port of wild-type Pma1 protein.
expression of dominant negative protein also blocks the The secretion of the nondominant lethal P536A,
transport of wild-type Pma1 and leads to its colocaliza- P536V, P536L, P536I, P536N, and P536T proteins was
tion in the same structures (Harris et al. 1994). To also studied. We introduced the HA epitope in the mu-
date, all dominant lethal PMA1 alleles identi®ed exhibit tant proteins, and HA-tagged proteins were expressed
the same phenotype (Harris et al. 1994; Portillo under the control of the GAL1 promoter. We examined
1997). To test whether the dominant lethal mutations the location of each of these HA-tagged mutant proteins
detected here also interefered with wild-type Pma1 tar- by immuno¯uorescent staining after galactose induc-
geting to the plasma membrane, we studied the trans- tion. The anti-HA antibody decorated the cell periphery
port of wild-type ATPase to the cell surface when domi- in all the cases (data not shown), except in cells express-
nant negative alleles are also expressed. To this end, ing the HA-tagged P536N protein, in which it accumu-
lated in subplasma membrane structures reminiscent ofwe introduced the HA epitope in the wild-type Pma1
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Figure 3.ÐAccumulation of the recessive lethal HA-tagged
P536N protein in cytoplasmic structures. The transformant
carried either the HA-tagged PMA1 or HA-tagged P536N genes
under the control of the GAL1 promoter. After galactose in-
duction, cells were stained for the nucleus (DAPI) or for the
HA-tagged protein (anti-HA).
tained; both were Ura2 (15 tetrads studied in each of
the diploids), thus con®rming that pma1-P536N is a re-
cessive lethal allele.
Pro-536 is located within the sequence motif 534DPPR,
which is fully conserved among all eukaryotic, cation-
transporting ATPases (Serrano 1989; Goffeau and
Green 1990; Wach et al. 1992) and is believed to form
part of the ATP-binding site (Rao et al. 1989; Serrano
1991). This prompted us to further characterize the
effect of Pro-536 substitution on enzyme function. The
P536A, P536V, P536L, P536I, or P536T mutant genes
were placed under the control of a heat-shock-inducible
promoter in the plasmid YCp2HSE (Nakamoto et al.
1991). Plasmids YCp2HSE containing the mutant genes
were transformed into strain SY4 (Nakamoto et al.
1991). This strain has the chromosomal PMA1 gene
under control of the GAL1 promoter and also carries
the temperature-sensitive sec6-4 mutation that blocks
fusion of secretory vesicles with the plasma membrane.
Thus, when cells were incubated in galactose medium
at 238, the chromosomal wild-type ATPase was pro-Figure 2.ÐAccumulation of wild-type HA-tagged Pma1 in
cells expressing dominant lethal Pro-536 mutations. Trans- duced, and when the cells were transferred to glucose
formants carried the HA-tagged PMA1 gene and either the medium at 378, the expression of the wild-type ATPase
wild-type or the indicated dominant lethal allele under the
was repressed and the mutant ATPase was expressed.control of the GAL1 promoter. Expression of the GAL::pma1
Because strain SY4 carries a temperature-sensitivegenes was induced with galactose for 5 hr. Panels show staining
of the nucleus (DAPI) or immuno¯uorescence using a rhoda- sec6-4 mutation, the shift to 378 also led to the accumula-
mine-conjugated anti-HA antibody (anti-HA Ab). tion of the newly synthesized mutant ATPase in secretory
vesicles. Secretory vesicles were puri®ed by differential
centrifugation for analysis of the newly synthesized mu-
those observed for dominant negative proteins (Figure tant ATPase (Nakamoto et al. 1991). Table 2 summa-
3). In contrast to dominant lethal proteins, the P536N rizes the behavior of the mutant enzymes. In all the
protein does not block transport of wild-type Pma1 pro- mutants, expression levels were signi®cantly higher than
tein to the cell surface (data not shown). This may that of the wild-type protein and, similarly, all had rela-
indicate that the P536N mutation renders a recessive tively high ATPase activity and H1-pumping rates. After
lethal pma1 allele, which was con®rmed by analyzing correction for the amount of Pma1, values ranged from
the segregation of the heterozygous diploid pma1- 60% hydrolysis/53% pumping in P536A to 114% hydro-
P536N::URA3/PMA1 (see materials and methods). lysis/93% pumping in P536I. Other kinetic properties
After sporulation and tetrad dissection of two indepen- assayed, Km for ATP and K i for orthovanadate, appeared
to be essentially wild type. Thus, it appears that Pro-536dent diploids, only two viable spores/tetrad were ob-
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TABLE 2
Effect of Pro536 replacements on expression, ATP hydrolysis, proton transports, and kinetic properties of ATPase
ATPaseb H1 transportd
Amount of Uncorrected Corrected Km (ATP)c K i (vanadate)c Uncorrected Corrected
Mutation ATPasea(%) (mmol/min/mg) (%) (mm) (mm) (%Q/mg) (%)
Wild-type 100 0.35 100 1.1 1.0 255 100
Nonee 5 0.02
P536A 200 0.42 60 0.9 1.3 270 53
P536V 250 0.96 109 1.3 1.0 590 93
P536L 350 1.10 90 1.3 1.0 710 80
P536I 150 0.60 114 1.2 1.5 355 93
P536T 350 1.20 98 1.1 0.9 760 87
a Quanti®ed by immunoassay. The value for the wild type was considered 100%.
b ATPase activity was assayed at pH 6.5 with 5 mm ATP. Values are the average of two independent experiments. Each mutant
value was corrected for expression relative to the wild-type control run in parallel.
c The Km was determined by varying ATP from 0.8 to 6 mm. The K i was determined by varying the concentration of vanadate
from 0 to 50 mm.
d Fluorescence quenching of acridine orange was used to monitor pumping of protons into secretory vesicles. Data for mutants
were corrected for expression relative to the parallel wild-type control.
e Secretory vesicles were isolated from SY4 transformed with the vector YCp2HSE carrying no PMA1 gene.
is not indispensable for enzyme activity and that the ATPase is a long-lived and metabolically stable protein
with a half-life of .20 hr (Benito et al. 1991), the ob-main defect of these Pro-536 substitutions seems to be
hyperaccumulation of enzymes in the secretory vesicles. served hyperaccumulation of newly synthesized P536L
protein at shorter times cannot be explained by changesTo determine whether or not the Pro-536 mutations
also led to hyperaccumulation of the mutant Pma1 pro- in the stability of the mutant protein. Thus, it seems that
Pro-536 may play an important role in the biogenesis oftein at the plasma membrane, we analyzed the transport
of wild-type and mutant enzymes to the cell surface. the plasma membrane ATPase.
Suppression spectrum of Pro-536 substitution: AfterCells expressing HA-tagged wild-type or mutant proteins
under the control of the GAL1 promoter were shifted phenotypic characterization of the mutant carrying the
Pro-536 mutation, the pma1-P536A, -P536V, -P536I, andfrom glucose- to galactose-containing medium, and
plasma membranes were puri®ed at different induction -P536T alleles were analyzed for competence to suppress
the R271T, D378N, D378E, and K474R dominant lethaltimes and analyzed by Western blot using anti-HA anti-
body. An example of this analysis is shown in Figure mutations. We combined the Pro-536 substitutions with
the dominant negative mutations in cis (see materials4 for wild-type and P536L Pma1 protein. The newly
synthesized HA-tagged P536L Pma1 protein is accumu- and methods). The new pma1 alleles were placed under
control of the GAL1 promoter and tested for dominantlated at the plasma membrane at levels higher than
those of the wild type. Considering that the wild-type lethality. The result of this intragenic suppression analy-
sis is shown in Table 3. The dominant lethality of the
R271T and D378N mutations was suppressed by any of
the Pro-536 substitutions tested, and none of the Pro-
536 mutations suppressed the lethality of the pma1-
TABLE 3
Intragenic suppression of lethal dominant mutations by
Figure 4.ÐAccumulation of wild-type and P536L proteins substitution at Pro-536
at the plasma membrane. Strains are recombinants carrying
either the HA-tagged PMA1 (HA ´ Pma1) or HA-tagged P536L
Dominant lethal mutations(HA ´ P536L) gene. Cells were grown in SL medium and
transferred to SG to induce the expression of the GAL::pma1 pma1 alleles R271T D378N D378E K474R
genes. At the times indicated, samples were taken and the
plasma membrane was puri®ed. Puri®ed plasma membrane P536A 1 1 2 2
was analyzed by immunoblot using monoclonal antibody P536V 1 1 2 1
12CA5 against the HA epitope (anti-HA) and Mab12 against P536I 1 1 2 2
Pma1 (anti-Pma1). The upper blot was intentionally devel- P536T 1 1 2 1
oped longer than the lower oneto detect expressed HA-tagged
Pma1 at shorter times. Mutations were combined and tested as described in Table 1.
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ishes retention of the proteins encoded by the dominant
lethal mutations at the ER and leads to transport of the
revertant enzymes to the cell surface.
Phenotype of yeast expressing the pma1-P536L allele:
The amount of Pma1 in the plasma membrane appears
to be tightly regulated, as overexpression of the ATPase
gene on a multicopy plasmid in yeast yields only a slight
increase in the amount of Pma1 in the plasma mem-
brane (Eraso et al. 1987). The fact that P536L mutant
enzyme expression signi®cantly increased the amount
of mutant Pma1 at the plasma membrane led us to
explore the phenotype of a yeast strain expressing only
the pma1-P536L allele. Two heterozygous diploids,
pma1-P536L::URA3/PMA1 (see materials and meth-
ods), were sporulated and tetrads were dissected. In all
tetrads studied, four viable spores/tetrad were obtained.
Three Ura1 haploid segregants containing the pma1-
P536L allele were selected to evaluate the physiological
consequences of the P536L mutant protein expression.
The results of this study are summarized in Table 4.
Yeast expressing the pma1-P536L allele showed a twofold
increase in the amount of Pma1 compared with the
wild-type strain. As a consequence, the in vitro ATPase
activity assayed in puri®ed plasma membrane was also
higher than that of the wild-type strain. Yeast cells ac-
tively extrude protons into the medium, an activity
caused by plasma membrane H1-ATPase, which re¯ects
the in vivo activity of the enzyme (Serrano 1980; CidFigure 5.ÐEffect of P536L mutation on localization of
et al. 1987) and correlates with both the in vitro ATPasedominant lethal Pma1 proteins. Transformants carried the
activity and the speci®c growth rate (Portillo and Ser-indicated HA-tagged pma1 allele under the control of the
GAL1 promoter. After galactose induction of the GAL1::pma1 rano 1989; Vallejo and Serrano 1989). It was there-
genes, cells were stained for immuno¯uorescence with a rho- fore expected that cells exhibiting high in vitro ATPase
damine-conjugated anti-HA antibody. activity would also show high H1-pumping activity rela-
tive to the wild-type cells. The fact that cells expressing
the P536L mutant enzyme exhibited lower H1-pumping
D378E allele. K474R was suppressed by the P536V and activity relative to the wild-type strain suggests that not
P536T, but not by the P536A mutations, which suggests all of the P536L mutant enzyme accumulated in the
that the bulkiness of the amino acid side chain is impor- plasma membrane is physiologically active or that the
tant for this intragenic suppression. mutant enzyme is only partially active. This is reinforced
Effect of Pro-536 substitutions on localization of by the fact that the speci®c growth rate of the mutant
dominant lethal Pma1: To understand how Pro-536 mu- cell decreased relative to that of the wild type.
tations suppress the dominant lethal alleles, it is neces-
sary to determine whether or not revertant mutant en-
DISCUSSIONzymes are still accumulated at Bip bodies. We examined
the transport of HA-tagged revertant enzymes. Cells Role of Pro-536 in ATPase function: Pro-536 is fully
expressing HA-tagged wild-type, dominant lethal, or conserved among all known members of the P-type
revertant proteins under the control of the GAL1 pro- ATPase family (Serrano 1989; Goffeau and Green
moter were shifted from glucose- to galactose-con- 1990; Wach et al. 1992). The P536A, P536V, P536L,
taining medium, and the location of the HA-tagged P536I, and P536T mutations resulted in active enzymes
proteins was examined by immuno¯uorescent staining that exhibited kinetic parameters similar to those of the
after galactose induction. Figure 5 shows, as an example, wild-type enzyme; therefore, at least in these cases, Pro-
the results obtained with the revertants generated from 536 does not appear to be essential for enzyme function.
the P536L mutation: R271T/P536L, D378N/P536L, The most remarkable phenotype of these enzymes ap-
D378E/P536L, and K474R/P536L. In contrast to the pears to be a hyperaccumulation at the cell surface. In
R271T, D378N, D378T, and K474R dominant negative contrast, enzymes bearing P536G, P536H, P536K, and
proteins, the revertant Pma1 proteins are localized at P536D mutations were defective in targeting to the
plasma membrane, as they are retained at the ER. Thesethe plasma membrane. This indicates that P536L abol-
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TABLE 4
Growth phenotype, ATPase activity, and expression of P536L mutant ATPase
Speci®c growth ATPase Amount of H1-pumping
Allele ratea,e activityb,e ATPasec,e activityd,c
PMA1 0.43 6 0.07 0.90 6 0.15 1.0 11 6 0.9
pma1-P536L 0.30 6 0.05 1.6 6 0.20 2.0 8 6 0.5
a h21.
b ATPase activity (mmol21 ´ min21 ´ mg protein21) was measured in puri®ed plasma membranes with 2 mm
ATP at pH 6.5.
c Quanti®ed by immunoassay in puri®ed plasma membrane. The value for the wild type was taken as 100%.
d Measured in whole cells (nmol H1 ´ min21 ´ mg fresh weight cells21).
e Values are the average of three independent experiments.
results suggest that the residue at position 536 may play based on the following arguments: P536L protein was
accumulated during yeast growth in a membrane frac-an important role in enzyme biogenesis. In wild-type
yeast cells, newly synthesized Pma1 is delivered to the tion that copuri®ed with the plasma membrane, and
immuno¯uorescence staining of yeast cells expressingplasma membrane via the secretory pathway (Holcomb
et al. 1988; Chang and Slayman 1991). Several lines of the HA-tagged P536L mutant protein with the anti-HA
antibody indicated that the mutant protein was localizedevidence suggest that transport of the protein to the
plasma membrane is under a tight control that mediates exclusively at the cell surface. An alternative hypothesis,
which could account for cell surface localization of thethe retention of either overexpressed wild-type (Supply
et al. 1993) or aberrant (Harris et al. 1994; Portillo mutant enzyme and yet low in vivo proton transport,
could be that the P536L mutant protein remains1997) Pma1 proteins at the ER. Although little is known
about both the mechanisms that mediate the retention trapped in subplasma membrane structures derived
from the plasma membrane. Based on the ®nding thatat the ER and the molecular determinants involved in
the targeting to the plasma membrane of the ATPase, the MOP2/END4 gene, which is required for receptor-
mediated and ¯uid-phase endocytosis (Raths et al.the ®nding that P536A, P536V, P536L, P536I, and
P536T mutant proteins are hyperaccumulated at the 1993), is also important to control the abundance of
Pma1 at the plasma membrane (Na et al. 1995), it seemscell surface raises the possibility that these mutants by-
pass some of the tight control on transport of the pro- reasonable to think that such subplasma membrane
structures could be derived from the plasma membranetein, thus improving the transport of the mutant enyzme
to the cell surface. by endocytosis. This hypothesis raises the possibility that
yeast cells could also control the amount of ATPaseWe found that yeast cells expressing only the pma1-
P536L mutant allele exhibited a signi®cantly decreased at the plasma membrane by regulating its endocytic
recycling. Nevertheless, the present results do not allowin vivo proton transport rate relative to both activity and
abundance of ATPase in puri®ed plasma membrane. us to dismiss an alternative model in which hyperaccu-
mulation of ATPase at the plasma membrane triggers aThis may indicate that not all of the accumulated mutant
ATPase is physiologically active. Several hypotheses can posttranscriptional mechanism that down-regulates the
ATPase. This type of down-regulation of ATPase hasbe considered to explain this striking phenotype. One
hypothesis could be that expression of P536L protein already been observed and is mediated by the plasma
membrane±associated protein kinase YCK1 (Estradawas detrimental to yeast growth. If expression of P536L
enzyme were toxic, there would be strong selective pres- et al. 1996). Data allowing discrimination between the
various possibilities might be provided by analyzing thesure during growth for the accumulation of second-site
mutations able to suppress the P536L mutation. This expression and activity of P536L protein in mutants
altered in endocytosis or YCK1.problem would not affect the P536L protein expressed
in secretory vesicles, as the mutant protein is transiently Mechanism of suppression of dominant lethal muta-
tions by the P536L mutation: We report here that P536Lexpressed in this case. Nevertheless, we rescued and
sequenced the pma1 allele after yeast growth, and only mutation suppresses the dominant lethality of the pma1-
R271T, -D378N, -D378E, and -K474R mutant alleles.the P536L mutation was present. However, extragenic
mutations cannot be completely discarded. The possibil- These dominant lethal pma1 alleles are located in differ-
ent regions of the ATPase: Arg-271 in the stalk region,ity that P536L mutant protein expression led to satura-
tion of the secretory pathway, resulting in proliferation Asp-378 in the phosphorylation domain, and Arg-474
in the ATP-binding domain (Rao et al. 1989; Serranoof internal membranes as a mechanism to control the
amount of Pma1 at the plasma membrane (Supply et al. 1991). Intragenic suppression analysis of selected pma1
mutations has suggested a conformational coupling be-1993; de Kerchove d'Exaerde et al. 1996), is discarded
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tween the stalk region and both the ATP-binding and could be responsible for suppression of pma1-R271T,
-D378N, -D378E, and -K474R dominant lethal alleles.-phosphorylation domains (Na et al. 1993; Harris et al.
1994; Maldonado and Portillo 1995). This structural Our genetic data cannot de®ne the position of these
residues within the tertiary structure of the ATPase, butcoupling could explain the suppression pattern of the
P536L mutation. Some speci®city is observed for sup- they indicate that these residues could interact with Pro-
536. Such interaction might contribute to the correctpression of the Asp-378 substitution, as the P536L muta-
tion suppresses the dominant lethality caused by conser- folding of the ATPase that is needed for proper localiza-
tion of the enzyme. If dominant lethal mutations disturbvative changes (D378 → N, E), but not that induced by
a nonconservative substitution (D378 → T) (Table 1). such interactions, Pro-536 suppressor mutations could
act as compensatory mutations by restoring those inter-Some steric requirements are also observed for suppres-
sion of the K474R and D378E mutations. In this case, actions, thus allowing proper folding and transport to
the plasma membrane. Conformational analysis of poly-the bulkiness of the amino acid side chain at position
536 appears to be important for suppression (Table peptides containing the dominant lethal and/or the
Pro-536 suppressor mutations could provide data sup-3). Although dominant lethal proteins are accumulated
into cytoplasmic structures (Harris et al. 1994), we porting this hypothesis.
showed that the P536L mutation suppresses the mislo- We are indebted to Carolyn Slayman for SY4, pPMA1.2, and
calization defect caused by the dominant lethal muta- YCp2HSE-PMA1; Jim Haber for XZ611; Jorge PeÂrez-Martin for
providing the anti-HA antibody and RamoÂn Serrano for providingtions, leading to transport of the revertant enzymes to
the anti-Pma1 antibody; MarõÂa J. MazoÂ n and Pilar Eraso for criticalthe cell surface. There are several mechanisms by which
reading of the manuscript; and Antonio FernaÂndez for help withthe P536L mutation might correct the mislocalization
the art work. Ana M. Maldonado and Natalia de la Fuente were
of R271T, D378N, D378E, and K474R mutant proteins. recipients of fellowships from the Gobierno Vasco and the Ministerio
The easiest interpretation is that revertant proteins are de EducacioÂn y Ciencia, respectively. This study was supported by
Spanish Grant DGICYT-PB94-0096.localized more ef®ciently at the plasma membrane,
merely because of the improved transport caused by the
P536L mutation. This explanation, however, although
feasible, does not account for the observed speci®city LITERATURE CITED
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